Prostate Cancer - Results from #27760

Role of neuroendocrine cells in prostate cancer progression - Abstract June 6, 2011

Data presented at the 47th American Society of Clinical Oncology (ASCO) annual meeting demonstrate the potential of circulating tumor cells (CTC) as a biomarker for metastatic prostate cancer clinical trials June 6, 2011

Editor's Commentary - The genomic complexity of primary human prostate cancer June 6, 2011

Effect of age, family history of prostate cancer, prostate enlargement and seasonality on PSA levels in a contemporary cohort of healthy Italian subjects - Abstract June 5, 2011

Parameters to improve the specificity of the prostate-specific antigen: Early detection of prostate cancer - Abstract June 4, 2011

The role of lymph node dissection in the management of prostate cancer - Abstract June 3, 2011

Radiation therapy and androgen deprivation in the management of high risk prostate cancer - Abstract June 3, 2011

National Cancer Institute Prostate Cancer Genetics Workshop - Abstract June 3, 2011

Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen dependent prostate cancer - Abstract June 3, 2011

Andropause syndrome in men treated for metastatic prostate cancer: A qualitative study of the impact of symptoms - Abstract June 3, 2011

Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer - Abstract June 3, 2011

The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series - Abstract June 3, 2011

Quantification of extraprostatic perineural spread and its prognostic value in pT3a pN0 M0 R0 prostate cancer patients - Abstract June 3, 2011

Assessing muscle function of the male pelvic floor using real time ultrasound - Abstract June 3, 2011

Pathways of chemotherapy resistance in castration-resistant prostate cancer - Abstract June 3, 2011

Editor's Commentary - High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy June 3, 2011

XMRV, prostate cancer and chronic fatigue syndrome - Abstract June 2, 2011

Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU) - Abstract June 2, 2011

Preventive care in prostate cancer patients: Following diagnosis and for five-year survivors - Abstract June 2, 2011

The application of natural orifice surgery for adenocarcinoma of the prostate - Abstract June 2, 2011

Page 1389 of 1435